ALISO VIEJO, Calif.,
Nov. 20, 2014 /PRNewswire/
-- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today
announced that company management will present an overview of the
company at the following conferences in December.
- Deutsche Bank 2014 BioFEST
- Presentation date: Tuesday, December 2,
2014
- Presentation time: 11:05 a.m.
E.T.
- Piper Jaffray 26th
Annual Healthcare Conference
- Presentation date: Wednesday, December
3, 2014
- Presentation time: 9:30 a.m.
E.T.
A live webcast and 30-day archive of these presentations will be
available at http://ir.avanir.com.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company
focused on bringing innovative medicines to patients with central
nervous system disorders of high unmet medical need. As part of our
commitment, we have extensively invested in our pipeline and are
dedicated to advancing medicines that can substantially improve the
lives of patients and their loved ones. For more information about
Avanir, please visit www.avanir.com.
AVANIR® is a trademark or registered trademark of Avanir
Pharmaceuticals, Inc. in the United
States and other countries.
©2014 Avanir Pharmaceuticals, Inc. All Rights Reserved.
Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700
Logo -
http://photos.prnewswire.com/prnh/20130207/LA55901LOGO
SOURCE Avanir Pharmaceuticals, Inc.